ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,715.87
      0.23%
      US Tech 100
      19,316.00
      0.10%
      Dow Jones
      42,093.47
      0.07%
      Brent Oil
      74.515
      0.85%
      Bitcoin
      63,536.17
      -0.14%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Sage Therapeutics Inc (SAGE) Quote

      Sage Therapeutics Inc

      Sage Therapeutics Inc (SAGE)

      Sage Potash Corp
      7.375
      -0.125
      ( -1.67% )
      Updated: 09:56:22
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      7.375
      Bid
      7.35
      Ask
      7.40
      Volume
      37,796
      7.26 Day's Range 7.53
      7.19 52 Week Range 28.26
      Market Cap
      450.247M
      Previous Close
      7.50
      Open
      7.53
      Last Trade
      11
      @
      7.375
      Last Trade Time
      09:56:35
      Financial Volume
      $ 280,328
      VWAP
      7.4169
      Average Volume (3m)
      768,868
      Shares Outstanding
      61,050,418
      Dividend Yield
      -
      PE Ratio
      -0.85
      Earnings Per Share (EPS)
      -8.87
      Revenue
      86.46M
      Net Profit
      -541.49M

      About Sage Therapeutics Inc

      Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the study of the nervous system and brain to discover medicines to treat life-threatening, rare central nervous system disorders. The company's lead development program is SAGE-217 program which is in Phase 3 clinical tri... Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the study of the nervous system and brain to discover medicines to treat life-threatening, rare central nervous system disorders. The company's lead development program is SAGE-217 program which is in Phase 3 clinical trials for post-partum depression, essential tremor, Parkinson's disease, and major depressive disorder. The company is also developing several other compounds for treatment that are in the early stage of development. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.sagerx.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Sage Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker SAGE. The last closing price for Sage Therapeutics was $7.50. Over the last year, Sage Therapeutics shares have traded in a share price range of $ 7.19 to $ 28.26.

      Sage Therapeutics currently has 61,050,418 shares outstanding. The market capitalization of Sage Therapeutics is $457.88 million. Sage Therapeutics has a price to earnings ratio (PE ratio) of -0.85.

      Ask ADVFN Intelligence (AI)

      SAGE Latest News

      More News

      The Gross Law Firm Reminds Sage Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2024 - SAGE

      The Gross Law Firm Reminds Sage Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2024 - SAGE PR Newswire NEW YORK, Sept. 23, 2024 NEW YORK...

      4 hours ago
      PR Newswire (US)

      The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of October 28, 2024 in Sage Therapeutics, Inc. Lawsuit - SAGE

      The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of October 28, 2024 in Sage Therapeutics, Inc. Lawsuit - SAGE PR Newswire NEW YORK, Sept. 19, 2024 NEW YORK, Sept. 19, 2024...

      September 19 2024
      PR Newswire (US)

      Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers

      September 17 2024
      Edgar (US Regulatory)

      The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of October 28, 2024 in Sage Therapeutics Lawsuit - SAGE

      The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of October 28, 2024 in Sage Therapeutics Lawsuit - SAGE PR Newswire NEW YORK, Sept. 16, 2024 NEW YORK, Sept. 16, 2024...

      September 16 2024
      PR Newswire (US)

      Sage Therapeutics, Inc. Class Action: The Gross Law Firm Reminds Sage Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2024 - SAGE

      Sage Therapeutics, Inc. Class Action: The Gross Law Firm Reminds Sage Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2024 - SAGE PR...

      September 12 2024
      PR Newswire (US)

      SAGE INVESTOR ALERT: Edelson Lechtzin LLP Urges Sage Therapeutics, Inc. (NASDAQ: SAGE) Shareholders to Seek Legal Counsel About the Pending Securities Fraud Class Action

      SAGE INVESTOR ALERT: Edelson Lechtzin LLP Urges Sage Therapeutics, Inc. (NASDAQ: SAGE) Shareholders to Seek Legal Counsel About the Pending Securities Fraud Class Action PR Newswire NEWTOWN, Pa...

      September 05 2024
      PR Newswire (US)

      Sage Therapeutics Inc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SAGE

      Sage Therapeutics Inc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SAGE PR Newswire LOS ANGELES, Sept. 5, 2024 LOS ANGELES, Sept. 5, 2024 /PRNewswire/...

      September 05 2024
      PR Newswire (US)

      Sage Therapeutics Inc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SAGE

      Sage Therapeutics Inc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SAGE PR Newswire LOS ANGELES, Aug. 8, 2024 LOS ANGELES, Aug. 8, 2024 /PRNewswire/...

      August 08 2024
      PR Newswire (US)

      Form 4 - Statement of changes in beneficial ownership of securities

      August 07 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      August 07 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.495-6.289707750957.878.057.266460857.60704517CS
      4-1.105-13.03066037748.488.487.196213557.75943029CS
      12-3.485-32.090239410710.8613.477.197688689.63438835CS
      26-11.785-61.508350730719.1619.5157.19102536011.62877754CS
      52-12.105-62.140657084219.4828.267.1997127916.3965016CS
      156-37.875-83.701657458645.2559.997.1980247927.94686703CS
      260-158.335-95.5494538652165.71166.017.1980451441.24164707CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      KAVLKaival Brands Innovations Group Inc
      $ 1.7158
      (196.34%)
      		38.03M
      NVVENuvve Holding Corporation
      $ 7.07
      (80.36%)
      		20.4M
      TGLTreasure Global Inc
      $ 1.19
      (74.92%)
      		42.24M
      LASELaser Photonics Corporation
      $ 15.35
      (47.45%)
      		1.8M
      XPONExpion360 Inc
      $ 0.113
      (33.25%)
      		215.24M
      ELABElevai Labs Inc
      $ 0.112
      (-60.00%)
      		6.77M
      PRFXPainReform Ltd
      $ 0.5735
      (-25.63%)
      		180.98k
      ADTXAditxt Inc
      $ 0.2909
      (-23.97%)
      		582.88k
      ZJYLJin Medical International Ltd
      $ 3.12
      (-23.53%)
      		154.91k
      FRGTFreight Technologies Inc
      $ 0.0875
      (-23.11%)
      		10.33M
      XPONExpion360 Inc
      $ 0.113
      (33.25%)
      		215.24M
      INTCIntel Corporation
      $ 22.3595
      (2.38%)
      		48.81M
      KXINKaixin Holdings
      $ 0.0865
      (13.82%)
      		45.6M
      TGLTreasure Global Inc
      $ 1.19
      (74.92%)
      		42.24M
      KAVLKaival Brands Innovations Group Inc
      $ 1.7158
      (196.34%)
      		38.03M

      SAGE Discussion

      View Posts
      Monksdream Monksdream 6 months ago
      SAGE over $10
      👍️0
      everton44 everton44 1 year ago
      SAGE going to 36 dollars, every article and financial companies downgrading SAGE yet it goes up big. HAHAHA
      👍️0
      gail gail 1 year ago
      i dont know anything about…

      …

      shorting. i am a simpleton, lol, i just trade like a normal trader.

      not in this one, but made a bundle on my last few trades, including ttoo today. weeee!!
      👍️0
      everton44 everton44 1 year ago
      we are all short selling the piss out of this now, come on board
      👍️0
      gail gail 1 year ago
      so, they got approved yet…

      ..

      it dropped huge today? im not in it but watching.
      👍️0
      AGORDON AGORDON 1 year ago
      FDA approved Zuranolone for PPD. CRL for Major Depressive.
      👍️0
      AGORDON AGORDON 1 year ago
      The FDA is still considering whether to approve zuranolone for clinical depression in addition to postpartum depression, but did not issue a decision on that indication.
      👍️0
      budgetthis budgetthis 2 years ago
      I was gonna burn some SAGE today, in a therapeutic manner, like they do on Yellowstone to ward off evil spirits.

      But no need……elevators going up today……lol.

      $$ SAGE $$
      👍️0
      CjMitts CjMitts 3 years ago
      Called the pump, How'd I know, garbby 10q report, RSI divergence. will be loading this at the bottom though with the money I make from this short, the potential of this companies pipeline is enormous.
      👍️0
      CjMitts CjMitts 3 years ago
      Boom
      👍️0
      CjMitts CjMitts 3 years ago
      Dont be fooled by the pump. Will be loading between 34-26. Surprised there's no talk on this page regarding the potential of this companies pipeline.
      👍️0
      thumper1 thumper1 5 years ago
      im out high 68.eom
      👍️0
      thumper1 thumper1 5 years ago
      bought 67.11. we will see
      👍️0
      NYCPuglet NYCPuglet 5 years ago
      Sold at 77. Thank god. Lol.
      👍️0
      NYCPuglet NYCPuglet 5 years ago
      In 1000 @ at 73. Easy profit flipper here. Very big whales behind this company.
      👍️0
      Daysinn4610 Daysinn4610 5 years ago
      Ceo cfo cso all buying shares https://www.gurufocus.com/news/999044/sage-therapeutics-inc-sage-president--ceo-jeffrey-m-jonas-bought-481500-of-shares
      👍️0
      Daysinn4610 Daysinn4610 5 years ago
      Some sage news https://www.streetinsider.com/dr/news.php?id=16261148
      👍️0
      keekee keekee 5 years ago
      Lol....brig6and early. Crossing $80 today? The $125 may actually happen by the end if the month? We will see.
      👍️0
      keekee keekee 5 years ago
      Seen this...though it is going to be just a few days apart. Congrats to BULLS....and I sure hope those that jumped in to short because I highlighted the stock GO BANKRUPT!!!
      👍️0
      keekee keekee 5 years ago
      $74 now. Everyone that shorted past week is now in red. And it will get even more painful going forward. Sorry, losers!
      👍️0
      keekee keekee 5 years ago
      $3 to $4 a day is fine for now. In a week or so we wi6see doing more than that number as we race back towards $125. When I saw BUY...and some.fools sell, all I think of is, Who the hell is their father!!!! Who do they get information from...David Einhorn or who? He just did 34% loss last year and is on track to be smothered again with the TSLA outperformance. We are headed up....Intelsat, SAGE, ASLN, FRAN, And a host of others.
      👍️0
      keekee keekee 5 years ago
      We're headed to $80 very likely today. It's a one way train here m.j till.$100.
      👍️0
      Biobonic Biobonic 5 years ago
      Post-hoc analysis revealed that in the MOUNTAIN Study, approximately 9% of patients in the SAGE-217 30 mg group had no measurable drug concentration, consistent with non-compliance in taking SAGE-217

      In the 30mg group, 192 received the medication at the onset of the trial.

      9% would approximate: 17 participants.

      The trial had 28 participants withdraw by day 42. (14%) a significant number, especially since there was a good measure of efficacy.



      👍️0
      RJ Trotts RJ Trotts 5 years ago
      I got out with 4.50 per share profit, we are both happy, enjoy your weekend. Hoping to find more winners next week.
      👍️0
      Nebuchadnezzar Nebuchadnezzar 5 years ago
      Caught this falling knife yesterday, out up $6.45 profit
      👍️0
      keekee keekee 5 years ago
      Watch when this stock went down from $68 yestersay. That was when I intentionally posted that I loaded. They came.and brought the it down. I reloaded. And they sre still here. Ditto for PTGX, 1, PRTY, AIHS, ASLN, AFH, SLDB, AFI, CBAY, ATIS. and a couple more. The have shorted most of these floats over 100% but still.manages tonhang on because folks have no idea that these stocks will fly double or triple. But check those out and good luck. They are mostly DOUBLERS in a month or two.
      👍️0
      keekee keekee 5 years ago
      There are folks that short anything I buy. They are the idiots holding this down. CV lick on my name to see other stocks we play opposite. They have money but no brain. Investor money. They will shi ort anything I posted that I bought under any circumstance. They are the knes here. Ignote the selling and load. This will fly!!!
      👍️0
      T695 T695 5 years ago
      I think we at resistance in the $66 are. The entire market will be over bought in a minute and this will sell off hard
      👍️0
      keekee keekee 5 years ago
      Minimum close today will be $70. I will take that..from $54 and lower entry yesterday. This one is as easy...easy. will likely be trending toward $100 by month end
      👍️0
      T695 T695 5 years ago
      Looks like my first outlook was the right one
      👍️0
      VictorMasonIsRight VictorMasonIsRight 5 years ago
      SAGE test compromised by 9 non compliant patients?
      Otherwise would have met all benchmarks?

      https://investorshub.advfn.com/boards/read_msg.aspx?message_id=152647122
      👍️0
      RJ Trotts RJ Trotts 5 years ago
      up in pre-market right now, here's to hoping it bounces nicely
      👍️0
      T695 T695 5 years ago
      On second thoughts, might me another 20% or so haircut today after all the downgrades
      👍️0
      T695 T695 5 years ago
      It’s way over sold, but still could fall to 50ish
      👍️0
      T695 T695 5 years ago
      I’m thinking we get a bounce from here to $66-67ish, when if it hits there it may either run back to low 70’s or pull back to 50’s then run to $70’s.... either way I see lows 50’s and lows 70’s as short term bottom and top
      👍️0
      RJ Trotts RJ Trotts 5 years ago
      May add some here after hours, and see if it will bounce tomorrow. Best to all here. Hoping it is oversold!
      👍️0
      keekee keekee 5 years ago
      Unfortunately, I brought them over..I mean the heavy sellers. These guys are blind in their rabid quest to trade against me. But I create losses for them. That is my mission now. We will see $100. The clueless sellers know it too!
      👍️0
      keekee keekee 5 years ago
      Will cross $80 tom8. Must $100 by next week. The fools selling are misguided
      👍️0
      T695 T695 5 years ago
      Might see by EOD
      👍️0
      keekee keekee 5 years ago
      This thing may actually return to $1.25 by year end. That would be over 200% for.me. lol. In at $54 and lower..pre.
      👍️0
      keekee keekee 5 years ago
      Loaded premkt at $53. Must get $100. Drug did not fail if you factor in the 9 candidates that did not take it. $100..let's go
      👍️0
      T695 T695 5 years ago
      Make take a nibble at $50
      👍️0
      altruism altruism 5 years ago
      4 according to 1 news source I saw
      👍️0
      Awl416 Awl416 5 years ago
      How many billions that she’s off the market cap - wow
      👍️0
      NYCPuglet NYCPuglet 6 years ago
      Such an easy predictable stock.
      👍️0
      cvm101 cvm101 6 years ago
      So this Leerink Swann call of 1/7 is looking pretty idiotic now as stock crosses $144.00
      Earlier they had downgraded and lowered target price to $80.00

      Sage Therapeutics stock price target raised to $90 from $80 at Leerink
      👍️0
      NYCPuglet NYCPuglet 6 years ago
      Once again it drops. Gotta love this flipper.
      👍️0
      NYCPuglet NYCPuglet 6 years ago
      Wish I had funds last week to throw in. I sensed a big pop was coming.
      👍️0
      cvm101 cvm101 6 years ago
      Well it has been - but with the approval to market the new drug its less a speculation and more an investable company. Longer term its worth $200. Most analyst target prices are in that area.
      👍️0
      NYCPuglet NYCPuglet 6 years ago
      Yep. This is an insane flipper stock.
      👍️0

      Your Recent History

      NASDAQ
      SAGE
      Sage Therapeutics
      Delayed Upgrade Clock